TABLE 2.
Resistance of clinical isolates from CF patients to conventional antimicrobial agentsa
Pathogen (no. of strains) | % Resistance to:
|
||||||
---|---|---|---|---|---|---|---|
TIM | CAZ | MEM | CIP | TOB | AMK | SXT | |
P. aeruginosa(n = 24) | 67 | 71 | ND | 33 | 63 | 67 | ND |
B. cepacia(n = 5) | 67 | 100 | 100 | 100 | ND | ND | 100 |
S. maltophilia(n = 5) | 100 | 100 | 100 | 80 | 100 | ND | 100 |
A. xylosoxidans(n = 5) | 80 | 40 | ND | 80 | 100 | 100 | ND |
Abbreviations: TIM, Timentin; CAZ, ceftazidime; MEM, meropenem; CIP, ciprofloxacin; TOB, tobramycin; AMK, amikacin; SXT, trimethoprim-sulfamethosoxazole; ND, not determined.